Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Galera Therapeutics Inc
(NQ:
GRTX
)
0.1450
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Galera Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 30, 2021
Gainers Kiora Pharmaceuticals (NASDAQ:KPRX) stock moved upwards by 20.4% to $1.06 during Thursday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
(GRTX) - Analyzing Galera Therapeutics Inc's Short Interest
December 29, 2021
Galera Therapeutics Inc's (NASDAQ:GRTX) short percent of float has risen 14.61% since last its last report. The company recently reported that it has 739.10 thousand shares sold...
Via
Benzinga
Peering Into Galera Therapeutics Inc's Recent Short Interest
December 28, 2021
Galera Therapeutics Inc's (NASDAQ:GRTX) short percent of float has risen 14.61% since last its last report. The company recently reported that it has 739.10 thousand shares sold...
Via
Benzinga
(GRTX) - Analyzing Galera Therapeutics Inc's Short Interest
December 23, 2021
Galera Therapeutics Inc's (NASDAQ:GRTX) short percent of float has fallen 59.47% since last its last report. The company recently reported that it has 645.00 thousand shares sold...
Via
Benzinga
(GRTX) - Analyzing Galera Therapeutics Inc's Short Interest
December 22, 2021
Galera Therapeutics Inc's (NASDAQ:GRTX) short percent of float has fallen 59.47% since last its last report. The company recently reported that it has 645.00 thousand shares sold...
Via
Benzinga
Galera Therapeutics Shares Surge As Citi Bumps Up Price Target To $20
December 20, 2021
Citi has
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 22, 2021
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 54.72% to $2.29 during Wednesday's pre-market session. The company's market cap stands at $...
Via
Benzinga
20 Stocks Moving in Wednesday's Pre-Market Session
December 22, 2021
Gainers BioRestorative Therapies, Inc. (NASDAQ: BRTX) rose 48.1% to $6.77 in pre-market trading after the company entered into a Master Service Agreement with PRC Clinical,...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 21, 2021
Gainers BioRestorative Therapies (NASDAQ:BRTX...
Via
Benzinga
The Global Breast Cancer Treatment Market Expected To Reach $34.06 Billion By End Of 2026
December 21, 2021
Palm Beach, FL – December 21, 2021 – FinancialNewsMedia.com News Commentary – Breast cancer is cancer that develops in the breast tissue. Breast cancer signs include the formation of a lump in the...
Via
FinancialNewsMedia
The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail
December 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CytomX Mid-Phase Study Of ADC In Lung And Head & Neck Cancer Patients...
Via
Benzinga
65 Biggest Movers From Yesterday
December 21, 2021
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock...
Via
Benzinga
38 Stocks Moving In Monday's Mid-Day Session
December 20, 2021
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares jumped 120.9% to $7.31 after the company reported addition to the Russell 2000 Index. Can-Fite BioPharma Ltd. (NYSE: CANF...
Via
Benzinga
The Week Ahead In Biotech (Dec. 19-25): Key Events Of Holiday-Shortened Week
December 19, 2021
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also drew strength from some...
Via
Talk Markets
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
December 19, 2021
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also...
Via
Benzinga
31 Stocks Moving In Thursday's Mid-Day Session
December 16, 2021
Gainers Calliditas Therapeutics AB (NASDAQ: CALT) shares climbed 28.7% to $24.13 after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 16, 2021
Gainers Calliditas Therapeutics (NASDAQ:CALT) stock rose 41.09% to $26.3 during Thursday's pre-market session. The market value of their outstanding shares is at $688....
Via
Benzinga
46 Biggest Movers From Yesterday
December 16, 2021
Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on...
Via
Benzinga
36 Stocks Moving In Wednesday's Mid-Day Session
December 15, 2021
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 15, 2021
Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 15, 2021
We're at the halfway point of the week but there's no slowing down as we dive into the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
December 15, 2021
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE:
Via
Benzinga
Ongoing R&D Leading to Discovery of More Efficient Therapies for Acute Myeloid Leukemia Therapeutics
December 15, 2021
Palm Beach, FL – December 15, 2021 – FinancialNewsMedia.com News Commentary – Acute Myeloid Leukemia (AML) is a type of blood cancer which usually affects white blood cells (WBCs), however, it can also...
Via
FinancialNewsMedia
20 Stocks Moving in Wednesday's Pre-Market Session
December 15, 2021
Gainers Galera Therapeutics, Inc. (NASDAQ: GRTX) rose 17.7% to $3.18 in pre-market trading after BTIG upgraded the stock from Neutral to Buy and announced a $15 price target....
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 14, 2021
Gainers Galera Therapeutics (NASDAQ:GRTX
Via
Benzinga
LEV Stock: The EV School Bus Deal That Pushed Lion Electric Higher Today
December 14, 2021
Lion Electric (LEV) stock was charging higher on Tuesday morning after the electric vehicle (EV) company revealed a new order contract.
Via
InvestorPlace
Benchmarks Extend Losses as Fed Meeting Kicks Off
December 14, 2021
Stocks are extending their selloff on Tuesday, with the Dow Jones Industrial Average giving back 164 points at midday, while the Nasdaq Composite and S&P 500 Index are both sporting sizeable losses as...
Via
Talk Markets
GRTX Stock Alert: The Surprising News That Has Galera Therapeutics Going Gangbusters Today
December 14, 2021
Galera Therapeutics (GRTX) stock is rocketing higher on Tuesday after the company revealed corrected results from a Phase 3 clinical trial.
Via
InvestorPlace
Why Galera Shares Are Surging More Than Double Today?
December 14, 2021
Galera Therapeutics Inc (NASDAQ: GRTX) has announced corrected results from its Phase 3 ROMAN trial of avasopasem for RT-induced severe oral mucositis (SOM) in...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 14, 2021
Gainers Galera Therapeutics (NASDAQ:GRTX) stock increased by 134.05% to $3.23 during Tuesday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.